1 / 4

Enfiera 100 mg | Rituximab | Blueberry pharmaceuticals

Enfiera 100 mg is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Enfiera has an approximate molecular weight of 145 kD @ Blueberry pharmaceuticals

sharonpaula08
Download Presentation

Enfiera 100 mg | Rituximab | Blueberry pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ENFIERA 100MG Enfiera 100mgis a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Enfiera has an approximate molecular weight of 145 kD. Enfiera has a binding affinity for the CD20 antigen of approximately 8.0 nm. Enfiera 100mg is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium that may contain the antibiotic gentamicin. Gentamicin is not detectable in the final product. Enfiera 100mg is an anticancer medicine which prevents the growth and spread of cancer cells in the body. Enfiera 100mg with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. INDICATED FOR Enfiera 100mg and hyaluronidase human injection are used as alone or concomitant use with other drugs to treat some types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC).

  2. Enfiera 100mg injection concomitant use with methotrexate (Otrexup, Rasuvo, Xatmep, others) is also used for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of drug knowns as tumor necrosis factor (TNF) inhibitor. Enfiera 100mg is a type in a classification of drugs called monoclonal antibodies. Enfiera 100mg is indicated to killing cancer cells to treat NHL, CLL, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis by preventing the activity of the immune system parts which can injury the joints, veins, and other blood vessels and cause organs (heart and lungs) damage. MECHANISM OF ACTION Rituximab (Enfiera 100mg) is belonging to a classification monoclonal antibody which aim the CD20 antigen declare on the surface of pre-B and mature B- lymphocytes. Upon connecting to CD20, rituximab intercedes B-cell lysis. Probably mechanisms of cell lysis contain complement dependent cytotoxicity (CDC) and antibody dependent cell mediated cytotoxicity (ADCC). B cells are believed to play a role in the pathogenesis of rheumatoid arthritis (RA) and analog to chronic synovitis.

  3. In this setting, B cells may be action at multiple sites in the autoimmune/inflammatory process, involving through production of rheumatoid factor (RF) and other autoantibodies, antigen presentation, T-cell activation, and/or proinflammatory cytokine production. SIDE EFFECTS(Enfiera 100mg) COMMON EFFECTS Fever and chills (flu lik symptoms) LESS COMMON SIDE EFFECTS Weakness; nausea; headache; cough;dyspnea ; pharyngitis PRECAUTIONS(Enfiera 100mg) Inform the doctor if Allergic condition against Enfiera 100mg or any other medication inform your doctor. Information about past medical history used which include in prescription, non-prescription, vitamins & supplements, nutritional products just inform the doctor. It will harm the baby unborn, while using Enfiera 100mg use correct birth control to prevent pregnancy and for at least 2 weeks after your treatment ends.

  4. It is unknown whether Enfiera 100mg passes into breast milk, avoid breast-feed while on Enfiera 100mg treatment. While using Enfiera 100mg do not take any vaccination or immunization without taking advice from doctors. CONTACT US : Email id : info@blueberrypharma.com Phone no :+91-97890 77748 Website : https://blueberrypharma.com/enfiera- 100mg.php

More Related